Myogenic induction of taurine transporter prevents dexamethasone-induced muscle atrophy.
Uozumi
Yoriko
Y
Department of Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan. uozumi@phs.osaka-u.ac.jp
Ito
Takashi
T
Takahashi
Kyoko
K
Matsuda
Takahisa
T
Mohri
Tomomi
T
Kimura
Yasushi
Y
Fujio
Yasushi
Y
Azuma
Junichi
J
D000818:Animals; D002454:Cell Differentiation / Q000502:physiology; D002460:Cell Line; D003907:Dexamethasone / Q000633:toxicity*; D005786:Gene Expression Regulation; D017930:Genes, Reporter; D008562:Membrane Glycoproteins / Q000235:genetics / Q000378:metabolism*; D026901:Membrane Transport Proteins / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D024510:Muscle Development / Q000502:physiology*; D018482:Muscle, Skeletal / Q000166:cytology / Q000473:pathology / Q000502:physiology; D009133:Muscular Atrophy / Q000139:chemically induced*; D013654:Taurine / Q000378:metabolism; D000099247:Taurine Transporters
D003907:Dexamethasone; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D013654:Taurine; D000099247:Taurine Transporters